Dysbindin, Syncoilin, and β-Synemin mRNA Levels in Dystrophic Muscles

REFERENCES

• Albrecht, D. E., & Froehner, S. C. (2004). DAMAGE, a novel α-dystrobrevin-associated MAGE protein in dystrophin complexes. The Journal of Biological Chemistry, 279(8), 7014–7023.
   PubMedGoogle Scholar
• Ambrose, H. J., Blake, D. J., Nawrotzki, R. A., & Davies, K. E. (1997). Genomic organization of the mouse dystrobrevin gene: Comparative analysis with the dystrophin gene. Genomics, 39(3), 359–369.
   PubMedGoogle Scholar
• Bellin, R. M., Huiatt, T. W., Critchley, D. R., & Robson, R. M. (2001). Synemin may function to directly link muscle cell intermediate filaments to both myofibrillar Z-lines and costameres. The Journal of Biological Chemistry, 276(34), 32330–32337.
   PubMedGoogle Scholar
• Benson, M. A., Newey, S. E., Martin-Rendon, E., Hawkes, R., & Blake, D. J. (2001). Dysbindin, a novel coiled-coil-containing protein that interacts with the dystrobrevins in muscle and brain. The Journal of Biological Chemistry, 276(26), 24232–24241.
   PubMedGoogle Scholar
• Blake, D. J., Hawkes, R., Benson, M. A., & Beesley, P. W. (1999). Different dystrophin-like complexes are expressed in neurons and glia. The Journal of Cell Biology, 147(3), 645–658.
   PubMedGoogle Scholar
• Blake, D. J., Nawrotzki, R., Peters, M. F., Froehner, S. C., & Davies, K. E. (1996). Isoform diversity of dystrobrevin, the murine 87-kDa postsynaptic protein. The Journal of Biological Chemistry, 271(13), 7802–7810.
   PubMed Web of Science ®Google Scholar
• Breen, G., Prata, D., Osborne, S., Munro, J., Sinclair, M., Li, T., (2006). Association of the dysbindin gene with bipolar affective disorder. The American Journal of Psychiatry, 163(9), 1636–1638.
   PubMedGoogle Scholar
• Brown, S. C., Torelli, S., Ugo, I., De Biasia, F., Howman, E. V., Poon, E., (2005). Syncoilin upregulation in muscle of patients with neuromuscular disease. Muscle & Nerve, 32(6), 715–725.
   PubMedGoogle Scholar
• Fukuyama, Y., Osawa, M., & Suzuki, H. (1981). Congenital progressive muscular dystrophy of the Fukuyama type—clinical, genetic, and pathological considerations. Brain & Development, 3(1), 1–29.
   PubMed Web of Science ®Google Scholar
• Granger, B. L., & Lazarides, E. (1980). Synemin: A new high molecular weight protein associated with desmin and vimentin filaments in muscle. Cell, 22(3), 727–738.
   PubMedGoogle Scholar
• Guo, A. Y., Sun, J., Riley, B. P., Thiselton, D. L., Kendler, K. S., & Zhao, Z. (2009). The dystrobrevin-binding protein 1 gene: Features and networks. Molecular Psychiatry, 14(1), 18–29.
   PubMedGoogle Scholar
• Howman, E. V., Sullivan, N., Poon, E. P., Britton, J. E., Hilton-Jones, D., & Davies, K. E. (2003). Syncoilin accumulation in two patients with desmin-related myopathy. Neuromuscular Disorders, 13(1), 42–48.
   PubMedGoogle Scholar
• Li, Z., Mericskay, M., Agbulut, O., Butler-Browne, G., Carlsson, L., Thornell, L. E., (1997). Desmin is essential for the tensile strength and integrity of myofibrils but not for myogenic commitment, differentiation, and fusion of skeletal muscle. The Journal of Cell Biology, 139(1), 129–144.
   PubMedGoogle Scholar
• Li, W., Zhang, Q., Oiso, N., Novak, E. K., Gautam, R., O’Brien, E. P., (2003). Hermansky-Pudlak syndrome type 7 (HPS-7) results from mutant dysbindin, a member of the biogenesis of lysosome-related organelles complex 1 (BLOC-1). Nature Genetics, 35(1), 84–89.
   PubMedGoogle Scholar
• McCullagh, K. J., Edwards, B., Poon, E., Lovering, R. M., Paulin, D., & Davies, K. E. (2007). Intermediate filament-like protein syncoilin in normal and myopathic striated muscle. Neuromuscular Disorders, 17(11–12), 970–979.
   PubMedGoogle Scholar
• Milner, D. J., Weitzer, G., Tran, D., Bradley, A., & Capetanaki, Y. (1996). Disruption of muscle architecture and myocardial degeneration in mice lacking desmin. The Journal of Cell Biology, 134(5), 1255–1270.
   PubMedGoogle Scholar
• Mizuno, Y., Guyon, J. R., Ishii, A., Hoshino, S., Ohkoshi, N., Tamaoka, A., (2007). β-synemin expression in cardiotoxin-injected rat skeletal muscle. BMC Musculoskeletal Disorders, 8, 40.
   PubMedGoogle Scholar
• Mizuno, Y., Guyon, J. R., Watkins, S. C., Mizushima, K., Sasaoka, T., Imamura, M., (2004). β-synemin localizes to regions of high stress in human skeletal myofibers. Muscle & Nerve, 30(3), 337–346.
   PubMedGoogle Scholar
• Mizuno, Y., Thompson, T. G., Guyon, J. R., Lidov, H. G., Brosius, M., Imamura, M., (2001). Desmuslin, an intermediate filament protein that interacts with α-dystrobrevin and desmin. Proceedings of the National Academy of Sciences of the United States of America, 98(11), 6156–6161.
   PubMedGoogle Scholar
• Nazarian, R., Starcevic, M., Spencer, M. J., & Dell’Angelica, E. C. (2006). Reinvestigation of the dysbindin subunit of BLOC-1 (biogenesis of lysosome-related organelles complex-1) as a dystrobrevin-binding protein. The Biochemical Journal, 395(3), 587–598.
   PubMedGoogle Scholar
• Newey, S. E., Howman, E. V., Ponting, C. P., Benson, M. A., Nawrotzki, R., Loh, N. Y., (2001). Syncoilin, a novel member of the intermediate filament superfamily that interacts with α-dystrobrevin in skeletal muscle. The Journal of Biological Chemistry, 276(9), 6645–6655.
   PubMedGoogle Scholar
• Pardo, J. V., Siliciano, J. D., & Craig, S. W. (1983). A vinculin-containing cortical lattice in skeletal muscle: Transverse lattice elements (“costameres”) mark sites of attachment between myofibrils and sarcolemma. Proceedings of the National Academy of Sciences of the United States of America, 80(4), 1008–1012.
   PubMedGoogle Scholar
• Poon, E., Howman, E. V., Newey, S. E., & Davies, K. E. (2002). Association of syncoilin and desmin: Linking intermediate filament proteins to the dystrophin-associated protein complex. The Journal of Biological Chemistry, 277(5), 3433– 3439.
   PubMedGoogle Scholar
• Sandoval, I. V., Colaco, C. A., & Lazarides, E. (1983). Purification of the intermediate filament-associated protein, synemin, from chicken smooth muscle. Studies on its physicochemical properties, interaction with desmin, and phosphorylation. The Journal of Biological Chemistry, 258(4), 2568–2576.
   PubMedGoogle Scholar
• Shah, S. B., Su, F. C., Jordan, K., Milner, D. J., Fridén, J., Capetanaki, Y., (2002). Evidence for increased myofibrillar mobility in desmin-null mouse skeletal muscle. The Journal of Experimental Biology, 205(Pt 3), 321–325.
   PubMedGoogle Scholar
• Starcevic, M., & Dell’Angelica, E. C. (2004). Identification of snapin and three novel proteins (BLOS1, BLOS2, and BLOS3/reduced pigmentation) as subunits of biogenesis of lysosome-related organelles complex-1 (BLOC-1). The Journal of Biological Chemistry, 279(27), 28393–28401.
   PubMed Web of Science ®Google Scholar
• Straub, R. E., Jiang, Y., MacLean, C. J., Ma, Y., Webb, B. T., Myakishev, M. V., (2002). Genetic variation in the 6p22.3 gene DTNBP1, the human ortholog of the mouse dysbindin gene, is associated with schizophrenia. American Journal of Human Genetics, 71(2), 337–348.
   PubMedGoogle Scholar
• Titeux, M., Brocheriou, V., Xue, Z., Gao, J., Pellissier, J. F., Guicheney, P., (2001). Human synemin gene generates splice variants encoding two distinct intermediate filament proteins. European Journal of Biochemistry, 268(24), 6435–6449.
   PubMedGoogle Scholar
• Wakayama, Y., Inoue, M., Kojima, H., Yamashita, S., Shibuya, S., Jimi, T., (2008). Reduced expression of sarcospan in muscles of Fukuyama congenital muscular dystrophy. Histology and Histopathology, 23(12), 1425–1438.
   PubMedGoogle Scholar
• Wilding, J. R., Schneider, J. E., Sang, A. E., Davies, K. E., Neubauer, S., & Clarke, K. (2005). Dystrophin- and MLP-deficient mouse hearts: Marked differences in morphology and function, but similar accumulation of cytoskeletal proteins. The FASEB Journal, 19(1), 79–81.
   PubMedGoogle Scholar
• Zhang, J., Bang, M. L., Gokhin, D. S., Lu, Y., Cui, L., Li, X., (2008). Syncoilin is required for generating maximum isometric stress in skeletal muscle but dispensable for muscle cytoarchitecture. American Journal of Physiology. Cell Physiology, 294(5), C1175–C1182.
   Google Scholar